Glitch For HLB/Hengrui’s Liver Cancer Combo After US CRL

Quick Resolution Of CMC Issues Expected

 
• By Jung Won Shin
  
rejection
HLB, Hengrui To Communicate With FDA, Refile As Soon As Possible • Source: Shutterstock
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from South Korea

More from Focus On Asia